Literature DB >> 16087355

Adaptation of the Folts and electrolytic methods of arterial thrombosis for the study of anti-thrombotic molecules in small animals.

Sharelle A Sturgeon1, Catherine Jones, James A Angus, Christine E Wright.   

Abstract

INTRODUCTION: Animal preparations of arterial thrombosis play a crucial role in the discovery and validation of novel drug targets in vivo, aiding in the selection of new drugs for clinical evaluation. The Folts and electrolytic methods of arterial thrombosis are two of the most commonly used techniques to investigate drugs with novel anti-thrombotic potential. However, these techniques often involved the use of large animals such as dogs, and their application to small animals was limited. The aim of the present study was to adapt the Folts and electrolytic methods previously described in large animals to create highly reproducible, quantitative models of arterial thrombosis in mice, rats and rabbits.
METHODS: Carotid artery blood flow was measured in anaesthetised mice, rats and rabbits. In the Folts-like method, a silk suture was tied around one carotid artery distal to a flow probe and tightened to cause a concentric stenosis sufficient to decrease blood flow by 50%. Intimal damage was induced by pinching the artery at the site of stenosis using forceps. The sequential formation and mechanical dislodgement of the resultant platelet-rich occlusive thrombus caused cyclic carotid artery flow reductions. In the electrolytic method in mice, a platinum hook electrode was placed distal to a flow probe on one carotid artery. The artery was clamped distally to the electrode to cause stasis and an electrical current (4 mA for 1.25 min) was applied before clamp release. This induced vascular injury resulting in occlusive thrombus (platelet- and fibrin-rich) formation.
CONCLUSION: The Folts-like method of arterial thrombosis was successfully adapted for use in mice, rats and rabbits, and the electrolytic technique for use in mice. Compared with larger animals, these methods are highly reproducible and ideal for pre-clinical, cost-effective, low-cost routine screening of novel anti-thrombotic drugs.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16087355     DOI: 10.1016/j.vascn.2005.06.006

Source DB:  PubMed          Journal:  J Pharmacol Toxicol Methods        ISSN: 1056-8719            Impact factor:   1.950


  11 in total

Review 1.  Tissue factor and thrombosis: The clot starts here.

Authors:  A Phillip Owens; Nigel Mackman
Journal:  Thromb Haemost       Date:  2010-06-10       Impact factor: 5.249

2.  Dok-2 adaptor protein regulates the shear-dependent adhesive function of platelet integrin αIIbβ3 in mice.

Authors:  Sascha C Hughan; Christopher M Spring; Simone M Schoenwaelder; Sharelle Sturgeon; Imala Alwis; Yuping Yuan; James D McFadyen; Erik Westein; Duncan Goddard; Akiko Ono; Yuji Yamanashi; Warwick S Nesbitt; Shaun P Jackson
Journal:  J Biol Chem       Date:  2014-01-02       Impact factor: 5.157

3.  The class II PI 3-kinase, PI3KC2α, links platelet internal membrane structure to shear-dependent adhesive function.

Authors:  Jessica K Mountford; Claire Petitjean; Harun W Kusuma Putra; Jonathan A McCafferty; Natasha M Setiabakti; Hannah Lee; Lotte L Tønnesen; James D McFadyen; Simone M Schoenwaelder; Anita Eckly; Christian Gachet; Sarah Ellis; Anne K Voss; Ross A Dickins; Justin R Hamilton; Shaun P Jackson
Journal:  Nat Commun       Date:  2015-03-17       Impact factor: 14.919

4.  Safety and efficacy of targeting platelet proteinase-activated receptors in combination with existing anti-platelet drugs as antithrombotics in mice.

Authors:  H Lee; S A Sturgeon; J K Mountford; S P Jackson; J R Hamilton
Journal:  Br J Pharmacol       Date:  2012-08       Impact factor: 8.739

5.  Adaptation of a photochemical method to initiate recurrent platelet-mediated thrombosis in small animals.

Authors:  Karin Przyklenk; Peter Whittaker
Journal:  Lasers Med Sci       Date:  2007-03       Impact factor: 3.161

6.  Platelet α-granules are required for occlusive high-shear-rate thrombosis.

Authors:  Dongjune A Kim; Katrina J Ashworth; Jorge Di Paola; David N Ku
Journal:  Blood Adv       Date:  2020-07-28

7.  A rat model of thrombosis in common carotid artery induced by implantable wireless light-emitting diode device.

Authors:  Jih-Chao Yeh; Kuo-Lun Huang; Yung-Chin Hsiao; Yu-Han Hsu; Yun-Han Lin; Shyh-Liang Lou; Tsong-Hai Lee
Journal:  Biomed Res Int       Date:  2014-06-19       Impact factor: 3.411

8.  Thrombolytic Recanalization of Carotid Arteries Is Highly Dependent on Degree of Stenosis, Despite Sonothrombolysis.

Authors:  Amelia J Tomkins; Rebecca J Hood; Debbie Pepperall; Christopher L Null; Christopher R Levi; Neil J Spratt
Journal:  J Am Heart Assoc       Date:  2016-02-23       Impact factor: 5.501

9.  Generation and characterization of tissue-type plasminogen activator transgenic rats.

Authors:  Yusuke Ito; Kengo Noguchi; Yoshiyuki Morishima; Kyoji Yamaguchi
Journal:  J Thromb Thrombolysis       Date:  2018-01       Impact factor: 2.300

10.  Tissue Plasminogen Activator for preclinical stroke research: Neither "rat" nor "human" dose mimics clinical recanalization in a carotid occlusion model.

Authors:  Amelia J Tomkins; Rebecca J Hood; Christopher R Levi; Neil J Spratt
Journal:  Sci Rep       Date:  2015-11-02       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.